Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. EBITDA for the year ending August 31, 2024: USD 11.24 M

Cannara Biotech Inc. EBITDA is USD 11.24 M for the year ending August 31, 2024, a -3.67% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2023 was USD 11.67 M, a 60.67% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2022 was USD 7.26 M, a 184.18% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2021 was USD 2.56 M, a 136.46% change year over year.
  • Cannara Biotech Inc. EBITDA for the year ending August 31, 2020 was USD -7.01 M, a 13.82% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email